releases: https://harris.house.gov/media/press-releases/congressman-harris-applauds-27-million-hhs-award-opioid-use-disorder-research
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://harris.house.gov/media/press-releases/congressman-harris-applauds-27-million-hhs-award-opioid-use-disorder-research | Congressman Harris Applauds $2.7 Million HHS Award for Opioid Use Disorder Research in Maryland's First District | 2026-06-17 | 2026 | 2026-06 | Republican | House | MD | Andy Harris | H001052 | harris.house.gov | harris | https://harris.house.gov/media/press-releases | scraper | WASHINGTON, D.C. — Congressman Andy Harris, M.D. (MD-01) today applauded the U.S. Department of Health and Human Services (HHS) for awarding $2,715,203 to Salisbury-based AKYSO Therapeutics LLC to continue research on a new treatment for opioid use disorder. Statement from Congressman Harris: "As a physician, I've seen how difficult opioid addiction is to overcome and the impact it has on patients, families, and loved ones. This research could help more patients stay in treatment, giving them a better chance at recovery. I thank the U.S. Department of Health and Human Services, the National Institutes of Health, and the National Institute on Drug Abuse for supporting this research, and I'm proud to see it taking place in Maryland's First District." | 1 | 2026-06-27T21:43:38Z | 2026-06-27T22:11:26Z |